HomeCGEM • NASDAQ
add
Cullinan Therapeutics Inc
Previous close
$8.49
Day range
$7.95 - $8.64
Year range
$7.95 - $30.19
Market cap
465.82M USD
Avg Volume
427.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.05M | 21.02% |
Net income | -47.65M | -100.17% |
Net profit margin | — | — |
Earnings per share | -0.73 | -35.19% |
EBITDA | -54.97M | -21.06% |
Effective tax rate | -0.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 398.98M | -14.58% |
Total assets | 621.82M | 28.43% |
Total liabilities | 31.50M | 3.99% |
Total equity | 590.33M | — |
Shares outstanding | 58.51M | — |
Price to book | 0.84 | — |
Return on assets | -21.59% | — |
Return on capital | -22.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -47.65M | -100.17% |
Cash from operations | -36.63M | -102.01% |
Cash from investing | 15.96M | -68.98% |
Cash from financing | 1.58M | 537.90% |
Net change in cash | -19.08M | -156.81% |
Free cash flow | -20.02M | -18.13% |
About
Founded
2016
Website
Employees
111
